Genomines

Paris, France · Founded 2021

Headquarters
Paris
Employees
11–50
Founded
2021
Business Model
B2B
Last Round
Series ASep 2025
Rounds
1

About

Genomines is a biotechnology and agriculture company that grows strategic metals. The company genetically enhances hyperaccumulator plants to extract battery-grade nickel from polluted soils, delivering high-grade metal at a fraction of the cost and emissions of traditional mining. Founded in 2021 by Fabien Koutchekian and Dr. Dali Rashid as part of the Entrepreneur First Paris cohort, Genomines operates labs in Paris and field operations in Johannesburg, serving battery and EV manufacturers seeking sustainable nickel supply.

Summary

Genomines is a Biotech company based in Paris, France, founded in 2021. Its most recent funding was a Series A round in Sep 2025. Investors include Engine Ventures, Forbion Capital Partners and Lowercarbon Capital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2025

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genomines on Indexed.vc
<a href="https://indexed.vc/companies/genomines"><img src="https://indexed.vc/api/badge/company/genomines" alt="Genomines on Indexed.vc" width="260" height="76" /></a>